Cardiac Valvulotome Market Revenue to Attain USD 176.06 Mn by 2033

25 Jul 2025

Share :

Table of Content

1. Cardiac Valvulotome Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Cardiac Valvulotome Market? 3. Segment Outlook 4. Regional Insights 5. Cardiac Valvulotome Market Coverage 6. Cardiac Valvulotome Market Key Players

Cardiac Valvulotome Market Revenue and Trends 2025 to 2033

The global cardiac valvulotome market revenue was valued at USD 121.34 million in 2025 and is expected to attain around USD 176.06 million by 2033, growing at a CAGR of 4.77% during forecast period. The market is growing rapidly due to a growing geriatric population, along with increasing prevalence of valvular heart diseases and rising preference for minimally invasive cardiac interventions. Ongoing advancements in medical devices further contribute to market growth.

What are the Major Factors Driving the Growth of the Cardiac Valvulotome Market?

The cardiac valvulotome market is experiencing significant growth, driven by the rise in the prevalence of heart valve diseases, such as aortic stenosis and mitral regurgitation. The demand for minimally invasive cardiac procedures is increasing, making the cardiac valvulotome a key device for safer valve procedures. This growth of the market is also driven by technological advances, better healthcare access, increased cardiovascular health awareness, and the rising prevalence of lifestyle-related conditions such as hypertension and obesity, which are linked to heart valve diseases. Emerging markets with increased healthcare spending create immense growth opportunities.

Segment Outlook

• By device type, the balloon valvulotomes segment led the market with a major revenue share in 2024. This is mainly due to their high precision and ease of use. The increased preference for minimally invasive heart valve surgical procedures further boosted the adoption of balloon valvulotomes.
• By indication, the pulmonary valve stenosis segment accounted for the majority of the share of the market share, backed by increased demand for minimally invasive procedures to treat this congenital narrowing. There is a high adoption of valvulotomes in clinics to treat pulmonary valve stenosis.
• By end-user, the tertiary care hospitals & cardiac centers segment held the largest share of the cardiac valvulotome market because of their advanced infrastructure, acquisition of a multidisciplinary cardiac group, and ability to manage valvulotomy procedures that are typically complex.

Regional Insights

North America registered dominance in the cardiac valvulotome market while holding the largest share in 2024. This is mainly due to its well-developed healthcare infrastructure, presence of major market players, and favorable reimbursement policies for cardiac procedures. There is a high prevalence of heart valve diseases and demand for minimally invasive procedures, contributing to market growth.

Meanwhile, Asia Pacific is expected to grow at the fastest rate in the upcoming period. This regional market growth is driven by increasing healthcare spending, expanding healthcare services in India, China, and Japan, and the growing prevalence of valvular heart diseases. In addition, the rising awareness of early disease treatment is likely to support market growth.

Cardiac Valvulotome Market Coverage

Recent Development

• In November 2024, Abbott announced the first patient procedures with its investigational transcatheter aortic valve implantation (TAVI) balloon-expandable system for treating symptomatic severe aortic stenosis.
  (Source: https://www.prnewswire.com)

Cardiac Valvulotome Market Key Players

• Medtronic
• Edwards Lifesciences
• Boston Scientific
• Abbott
• Cook Medical
• Terumo
• Philips (Spectranetics)
• LivaNova
• Micro Interventional Devices
• B. Braun
• Johnson & Johnson (Biosense Webster)
• CardioTech International

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6457

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.co |+1 804 441 9344